|
|
Volumn 306, Issue 2, 2011, Pages 143-
|
|
Diabetes drug may be associated with increase in risk of bladder cancer
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PIOGLITAZONE;
BLADDER CANCER;
CANCER RISK;
DIABETES MELLITUS;
DRUG CONTRAINDICATION;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG INFORMATION;
DRUG RECALL;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GLYCEMIC CONTROL;
HUMAN;
PATIENT COUNSELING;
PATIENT EDUCATION;
PRESCRIPTION;
PRIORITY JOURNAL;
RECURRENCE RISK;
RISK ASSESSMENT;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
SYMPTOM;
TREATMENT DURATION;
|
|
EID: 79960164790
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2011.939 Document Type: Short Survey |
|
Times cited : (19)
|
|
References (0)
|
